Newamsterdam Pharma Stock Price on December 16, 2024
| NAMSW Stock | 14.47 0.21 1.43% |
If you're considering investing in NewAmsterdam Stock, it is important to understand the factors that can impact its price. As of today, the current price of NewAmsterdam Pharma stands at 14.47, as last reported on the 29th of December, with the highest price reaching 14.47 and the lowest price hitting 14.46 during the day. NewAmsterdam Pharma is unstable given 3 months investment horizon. NewAmsterdam Pharma has Sharpe Ratio of 0.14, which conveys that the firm had a 0.14% return per unit of risk over the last 3 months. We are able to interpolate and collect twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.76% are justified by taking the suggested risk. Use NewAmsterdam Pharma Mean Deviation of 5.76, risk adjusted performance of 0.1245, and Downside Deviation of 7.69 to evaluate company specific risk that cannot be diversified away.
At this time, NewAmsterdam Pharma's Common Stock Shares Outstanding is fairly stable compared to the past year. Stock Based Compensation is likely to climb to about 25.8 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 260.6 M in 2024. . At this time, NewAmsterdam Pharma's Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to climb to 3.34 in 2024, despite the fact that Price Earnings To Growth Ratio is likely to grow to (0.05). NewAmsterdam Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
NewAmsterdam |
Sharpe Ratio = 0.1362
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | NAMSW | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.96 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.76 actual daily | 35 65% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average NewAmsterdam Pharma is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NewAmsterdam Pharma by adding it to a well-diversified portfolio.
Book Value 4.111 | Shares Float 36.3 M | Shares Short Prior Month 983 | Shares Short 151 | Revenue Per Share 0.373 |
Related Headline
NewAmsterdam Pharma Headline on 16th of December 2024
Menarini Group announces Positive Topline Data from Pivotal ... by finance.yahoo.com
Menarini Group today announces positive topline data from the Phase 3 BROADWAY and the Phase 3 TANDEM clinical trials sponsored by NewAmsterdam Pharma Company N.V. , a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease with elevated low-density lipoprotein cholesterol , for whom existing therapies are not sufficiently effec
NewAmsterdam Pharma Valuation on December 16, 2024
It is possible to determine the worth of NewAmsterdam Pharma on a given historical date. On December 16, 2024 NewAmsterdam was worth 13.12 at the beginning of the trading date compared to the closed value of 13.12. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NewAmsterdam Pharma stock. Still, in general, we apply an absolute valuation method to find NewAmsterdam Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NewAmsterdam Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NewAmsterdam Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 13.02 | 13.02 | 13.02 | 13.02 | 172.00 | |
12/16/2024 | 13.12 | 13.12 | 13.12 | 13.12 | 131.00 |
| 13.09 | 14.74 | 13.09 | 14.74 | 1,468 |
| Backtest NewAmsterdam Pharma | | | NewAmsterdam Pharma History | | | NewAmsterdam Pharma Valuation | Previous | Next |
NewAmsterdam Pharma Trading Date Momentum on December 16, 2024
| On December 17 2024 NewAmsterdam Pharma was traded for 14.74 at the closing time. The highest daily price throughout the period was 14.74 and the lowest price was 13.09 . The daily volume was 1.5 K. The net trading volume on 12/17/2024 added to the next day price increase. The trading delta at closing time to closing price of the next trading day was 12.35% . The trading delta at closing time to current closing price is 9.38% . |
NewAmsterdam Pharma Fundamentals Correlations and Trends
By evaluating NewAmsterdam Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NewAmsterdam Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NewAmsterdam financial account trend analysis is a perfect complement when working with valuation or volatility modules.About NewAmsterdam Pharma Stock history
NewAmsterdam Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NewAmsterdam is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NewAmsterdam Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NewAmsterdam Pharma stock prices may prove useful in developing a viable investing in NewAmsterdam Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 82.2 M | 86.3 M |
NewAmsterdam Pharma Quarterly Net Working Capital |
|
NewAmsterdam Pharma Stock Technical Analysis
NewAmsterdam Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
NewAmsterdam Pharma Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
NewAmsterdam Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
NewAmsterdam Pharma December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how NewAmsterdam Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NewAmsterdam Pharma shares will generate the highest return on investment. By undertsting and applying NewAmsterdam Pharma stock market strength indicators, traders can identify NewAmsterdam Pharma entry and exit signals to maximize returns
NewAmsterdam Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NewAmsterdam Pharma's price direction in advance. Along with the technical and fundamental analysis of NewAmsterdam Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NewAmsterdam to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1245 | |||
| Jensen Alpha | 1.86 | |||
| Total Risk Alpha | 1.48 | |||
| Sortino Ratio | 0.2359 | |||
| Treynor Ratio | (2.27) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for NewAmsterdam Stock Analysis
When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.